首页> 美国政府科技报告 >Novel Array-Based Target Identification for Synergistic Sensitization of Breast Cancer to Herceptin.
【24h】

Novel Array-Based Target Identification for Synergistic Sensitization of Breast Cancer to Herceptin.

机译:基于阵列的新靶点识别乳腺癌与赫赛汀的协同增敏作用。

获取原文

摘要

During the current six month funding period (9/07-2/08) we have built on the results of the prior progress report to use the methods of chromatins immunoprecipitation developed with Jun Kinase and applied these to examine HER2-dependent binding of RNA Polymerase II (RNPII) to the DNA of human breast cancer cell lines MCF7HER2, MCF7PCDNA, BT474, and MDA453. The goal is identify genes that the oncogene HER2 specifically stimulates for transcription or primes for transcription. The genes of the chromatin immunoprecipitatioin (ChIP) prepared DNA are identified by hybridizing the ChIP DNA to our in-house prepared arrays as for Jun Kinase and also Agilent promoter arrays with ~17,000 genes represented.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号